BG
AVEO

BlackRock Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

BlackRock Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,649
Closed -$178K – 2828
2013
Q3 		$178K Buy
8,649
+920
+12% +$21.1K ﹤0.01% 2513
2013
Q2 		$193K Buy
+7,729
New +$330K ﹤0.01% 2286

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group's AVEO Position: Q4 2013 in Review

BlackRock Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2013, closing a stake of 8,649 shares — an estimated $178K sold.

BlackRock Group first reported a position in AVEO in Q2 2013 and held it in 2 quarters. The position peaked at $193K in Q2 2013. 70 funds tracked by Wall St. Rank hold AVEO as of Q4 2013.

  • BlackRock Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 8,649 AVEO Pharmaceuticals, Inc. shares in Q4 2013, an estimated $178K.
  • BlackRock Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • BlackRock Group's AVEO Pharmaceuticals, Inc. position peaked at $193K in Q2 2013.
  • 70 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.